After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
VKTX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Viking Therapeutics Inc is $3.60B. A total of 4.06 million shares were traded on the day, compared to an average of 3.57M shares.
In the most recent transaction, ZANTE GREG sold 57,661 shares of VKTX for 32.90 per share on Jan 05 ’26. After the transaction, the Chief Financial Officer now owns 189,891 company shares. In a previous transaction on Jan 05 ’26, Mancini Marianna sold 57,661 shares at 32.98 per share. VKTX shares that Chief Operating Officer owns now total 409,190.
Among the insiders who sold shares, Lian Brian disposed of 233,409 shares on Jan 05 ’26 at a per-share price of $32.96. This resulted in the President & CEO holding 2,499,291 shares of VKTX after the transaction. In another insider transaction, FOEHR MATTHEW W sold 16,000 shares at $35.11 per share on Jan 02 ’26. Company shares held by the Director now total 132,036.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, VKTX has a high of $43.15 and a low of $18.92.
As of this writing, VKTX has an earnings estimate of -$0.9 per share for the current quarter. EPS was calculated based on a consensus of 14.0 estimates, with a high estimate of -$0.79 per share and a lower estimate of -$1.06. The company reported an EPS of -$0.32 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. VKTX’s latest balance sheet shows that the firm has $202.10M in Cash & Short Term Investments as of fiscal 2021. There were $29.00k in debt and $8.78M in liabilities at the time. Its Book Value Per Share was $6.34, while its Total Shareholder’s Equity was $201.88M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
